On the role of regulatory T cells during viral-induced inflammatory lesions

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5924-5933

  Veiga Parga, Tamara ^a   Suryawanshi, Amol ^b   Mulik, Sachin ^a   Giménez, Fernanda ^a   Sharma, Shalini ^c   Sparwasser, Tim ^d   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOREACTIVITY; INFLAMMATORY CELL; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TH1 CELL;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; GENES, REPORTER; HERPESVIRUS 1, HUMAN; INFLAMMATION; KERATITIS, HERPETIC; LYMPH NODES; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 84871161596     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202322     Document Type: Article

References (42)

1. Pepose, J. D. 1996. Herpes simplex virus disease: Anterior segment of the eye. In Ocular Infection and Immunity. J. S. Pepose, G. N. Holland, and K. R. Whlhelmus, eds. Vol. 27. Mosby, St. Louis, MO, p. 905-932.
2. Giménez, F., A. Suryawanshi, and B. T. Rouse. 2012. Pathogenesis of herpes stromal keratitis - a focus on corneal neovascularization. Prog. Retin. Eye Res. 10.1016/jpreteyeres.2012.07.002.
3. Niemialtowski, M. G., and B. T. Rouse. 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149: 3035-3039.
4. Hendricks, R. L., T. M. Tumpey, and A. Finnegan. 1992. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149: 3023-3028.
5. Suryawanshi, A., T. Veiga-Parga, N. K. Rajasagi, P. B. Reddy, S. Sehrawat, S. Sharma, and B. T. Rouse. 2011. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J. Immunol. 187: 1919-1930.
6. Sarangi, P. P., S. Sehrawat, S. Suvas, and B. T. Rouse. 2008. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J. Immunol. 180: 6297-6306.
7. Rajasagi, N. K., A. Suryawanshi, S. Sehrawat, P. B. Reddy, S. Mulik, M. Hirashima, and B. T. Rouse. 2012. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J. Immunol. 188: 4631-4643.
8. Sehrawat, S., A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182: 3191-3201.
9. Mulik, S., J. Xu, P. B. Reddy, N. K. Rajasagi, F. Gimenez, S. Sharma, P. Y. Lu, and B. T. Rouse. 2012. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am. J. Pathol. 181: 525-534.
10. Suvas, S., A. K. Azkur, B. S. Kim, U. Kumaraguru, and B. T. Rouse. 2004. CD4 +CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172: 4123-4132. (Pubitemid 38375224)
11. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360. (Pubitemid 41716772)
12. Sehrawat, S., S. Suvas, P. P. Sarangi, A. Suryawanshi, and B. T. Rouse. 2008. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J. Virol. 82: 6838-6851. (Pubitemid 351977705)
13. Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212: 8-27. (Pubitemid 44116697)
14. Tang, Q., and J. A. Bluestone. 2006. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212: 217-237. (Pubitemid 44116711)
15. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 27: 551-589.
16. Sehrawat, S., and B. T. Rouse. 2011. Tregs and infections: on the potential value of modifying their function. J. Leukoc. Biol. 90: 1079-1087.
17. Reuter, D., T. Sparwasser, T. Hünig, and J. Schneider-Schaulies. 2012. Foxp3+ regulatory T cells control persistence of viral CNS infection. PLoS ONE 7: e33989.
18. Zheng, M., S. Deshpande, S. Lee, N. Ferrara, and B. T. Rouse. 2001. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 75: 9828-9835. (Pubitemid 32900118)
19. Suryawanshi, A., S. Mulik, S. Sharma, P. B. Reddy, S. Sehrawat, and B. T. Rouse. 2011. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J. Immunol. 186: 3653-3665.
20. Dana, M. R., S. N. Zhu, and J. Yamada. 1998. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17: 403-409. (Pubitemid 28307507)
21. Veiga-Parga, T., A. Suryawanshi, and B. T. Rouse. 2011. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog. 7: e1002427.
22. Suvas, S., U. Kumaraguru, C. D. Pack, S. Lee, and B. T. Rouse. 2003. CD4 +CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 198: 889-901. (Pubitemid 37152926)
23. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341. (Pubitemid 40387475)
24. Kim, J., K. Lahl, S. Hori, C. Loddenkemper, A. Chaudhry, P. deRoos, A. Rudensky, and T. Sparwasser. 2009. Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J. Immunol. 183: 7631-7634.
25. Biswas, P. S., and B. T. Rouse. 2005. Early events in HSV keratitis - setting the stage for a blinding disease. Microbes Infect. 7: 799-810. (Pubitemid 40720435)
26. Zhang, X., S. Jiang, M. Manczak, B. Sugden, and G. Adamus. 2002. Phenotypes of T cells infiltrating the eyes in autoimmune anterior uveitis associated with EAE. Invest. Ophthalmol. Vis. Sci. 43: 1499-1508. (Pubitemid 34462650)
27. Devine, L., S. L. Lightman, and J. Greenwood. 1996. Role of LFA-1, ICAM-1, VLA-4 and VCAM-1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro. Immunology 88: 456-462. (Pubitemid 26225172)
28. Rouse, B. T., and S. Sehrawat. 2010. Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10: 514-526.
29. Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A. Hamann, H. Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204: 57-63. (Pubitemid 46148756)
30. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507. (Pubitemid 35477041)
31. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220-1224. (Pubitemid 351929511)
32. Zelinskyy, G., K. K. Dietze, Y. P. Hüsecken, S. Schimmer, S. Nair, T. Werner, K. Gibbert, O. Kershaw, A. D. Gruber, T. Sparwasser, and U. Dittmer. 2009. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood 114: 3199-3207.
33. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158: 1383-1391. (Pubitemid 127469965)
34. Tumpey, T. M., S. H. Chen, J. E. Oakes, and R. N. Lausch. 1996. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70: 898-904. (Pubitemid 26029006)
35. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
36. Masteller, E. L., Q. Tang, and J. A. Bluestone. 2006. Antigen-specific regulatory T cells - ex vivo expansion and therapeutic potential. Semin. Immunol. 18: 103-110. (Pubitemid 43248738)
37. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. (Pubitemid 350190247)
38. Zhao, Z. S., F. Granucci, L. Yeh, P. A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279: 1344-1347. (Pubitemid 28119574)
39. Boyman, O., C. D. Surh, and J. Sprent. 2006. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin. Biol. Ther. 6: 1323-1331. (Pubitemid 44875686)
40. Boyman, O., C. Krieg, S. Letourneau, K. Webster, C. D. Surh, and J. Sprent. 2012. Selectively expanding subsets of T cells in mice by injection of interleukin-2/antibody complexes: implications for transplantation tolerance. Transplant. Proc. 44: 1032-1034.
41. Schreiber, T. H., D. Wolf, and E. R. Podack. 2011. The role of TNFRSF25: TNFSF15 in disease... and health? Adv. Exp. Med. Biol. 691: 289-298.
42. Reddy, P. B. J., T. H. Schreiber, N. K. Rajasagi, A. Suryawanshi, S. Mulik, T. Veiga-Parga, T. Niki, M. Hirashima, E. R. Podack, and B. T. Rouse. 2012. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J. Virol. 86: 10606-10620